Stay updated on Ipragliflozin vs Sitagliptin in T2DM with SU+Met Clinical Trial
Sign up to get notified when there's something new on the Ipragliflozin vs Sitagliptin in T2DM with SU+Met Clinical Trial page.

Latest updates to the Ipragliflozin vs Sitagliptin in T2DM with SU+Met Clinical Trial page
- Check8 days agoChange DetectedRevision: v3.5.3 replaces the previous v3.5.2 on the page. This reflects a minor platform update to the study record interface.SummaryDifference0.1%

- Check15 days agoChange DetectedAdded “Type 2 diabetes” related topics, including a MedlinePlus Genetics section.SummaryDifference0.2%

- Check22 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.1%

- Check58 days agoChange DetectedMetadata updates include adding the topic 'Type 2 diabetes' and the related topic 'MedlinePlus Genetics', and the site revision updated from v3.4.2 to v3.4.3.SummaryDifference0.2%

- Check65 days agoChange DetectedRemoved 'Type 2 diabetes' and 'MedlinePlus Genetics' from the Related Topics section.SummaryDifference0.2%

Stay in the know with updates to Ipragliflozin vs Sitagliptin in T2DM with SU+Met Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipragliflozin vs Sitagliptin in T2DM with SU+Met Clinical Trial page.